DE69616276T2 - Verfahren zur produktion von proteinen - Google Patents

Verfahren zur produktion von proteinen

Info

Publication number
DE69616276T2
DE69616276T2 DE69616276T DE69616276T DE69616276T2 DE 69616276 T2 DE69616276 T2 DE 69616276T2 DE 69616276 T DE69616276 T DE 69616276T DE 69616276 T DE69616276 T DE 69616276T DE 69616276 T2 DE69616276 T2 DE 69616276T2
Authority
DE
Germany
Prior art keywords
producing proteins
protein
yeast
genes
concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69616276T
Other languages
English (en)
Other versions
DE69616276D1 (de
Inventor
Bernd Meyhack
Michael Broeker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Sanofi Aventis Deutschland GmbH
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG, Aventis Pharma Deutschland GmbH filed Critical Novartis Erfindungen Verwaltungs GmbH
Application granted granted Critical
Publication of DE69616276D1 publication Critical patent/DE69616276D1/de
Publication of DE69616276T2 publication Critical patent/DE69616276T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
DE69616276T 1995-02-09 1996-01-26 Verfahren zur produktion von proteinen Expired - Lifetime DE69616276T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95810084 1995-02-09
PCT/EP1996/000314 WO1996024678A1 (en) 1995-02-09 1996-01-26 Process for the production of proteins

Publications (2)

Publication Number Publication Date
DE69616276D1 DE69616276D1 (de) 2001-11-29
DE69616276T2 true DE69616276T2 (de) 2002-12-12

Family

ID=8221698

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616276T Expired - Lifetime DE69616276T2 (de) 1995-02-09 1996-01-26 Verfahren zur produktion von proteinen

Country Status (10)

Country Link
US (2) US5981227A (de)
EP (1) EP0801682B1 (de)
JP (1) JP3732516B2 (de)
AT (1) ATE207538T1 (de)
AU (1) AU707657B2 (de)
DE (1) DE69616276T2 (de)
DK (1) DK0801682T3 (de)
ES (1) ES2167537T3 (de)
PT (1) PT801682E (de)
WO (1) WO1996024678A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996024678A1 (en) * 1995-02-09 1996-08-15 Novartis Ag Process for the production of proteins
FR2801902B1 (fr) * 1999-12-01 2005-03-04 Centre Nat Rech Scient Procedes de criblages fonctionnels d'agents aptes a moduler l'activite des complexes ubiquitine-ligases scf et leurs applications
FR2823764B1 (fr) * 2001-04-24 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides du gene ifn alpha-17

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3479520D1 (en) 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
EP0205404B1 (de) 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid-Interferone
MY101203A (en) 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
CA1324969C (en) * 1988-05-06 1993-12-07 Jeffrey R. Shuster High level expression of proteins in yeast
EP0352060A3 (de) * 1988-07-21 1990-12-27 Takeda Chemical Industries, Ltd. Expressionsplasmid und dessen Verwendung
CA2002210C (en) * 1988-11-04 2001-04-24 Philip J. Barr Expression and processing of authentic fgf's in yeast
FI103206B (fi) * 1990-01-29 1999-05-14 Novartis Ag Uusi ilmentämisjärjestelmä sieniä varten
DE69515613T2 (de) * 1994-12-16 2000-11-30 Chiron Behring Gmbh & Co Immunogenes Hybridprotein OprF-Oprl erhältlich aus Membranproteinen von Pseudomonas aeruginosa
WO1996024678A1 (en) * 1995-02-09 1996-08-15 Novartis Ag Process for the production of proteins

Also Published As

Publication number Publication date
ES2167537T3 (es) 2002-05-16
EP0801682B1 (de) 2001-10-24
US5981227A (en) 1999-11-09
DK0801682T3 (da) 2002-02-18
JP3732516B2 (ja) 2006-01-05
AU707657B2 (en) 1999-07-15
WO1996024678A1 (en) 1996-08-15
EP0801682A1 (de) 1997-10-22
JPH10513353A (ja) 1998-12-22
PT801682E (pt) 2002-03-28
US6284520B1 (en) 2001-09-04
DE69616276D1 (de) 2001-11-29
AU4487496A (en) 1996-08-27
ATE207538T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
DE69231137T2 (de) Verfahren zur Herstellung von Peroxidasen in einem Aspergillusstamm
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE69532968T2 (de) Verfahren zur sekretion thrombopoitin polypeptide
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
FI854145A0 (fi) Pichia-sukuisten hiivojen transformointi
PL352332A1 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
DE59608743D1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation
ES2059478T3 (es) Co-expresion en celulas eucarioticas.
ATE47426T1 (de) Verfahren zur isolierung von gaerungsprodukten.
ATE316570T1 (de) Verfahren zur verminderung der schaumbildung während der kultivierung eines mikroorganismus
EP0341746A3 (de) Expression von Hepatitis B S und preS2 Proteinen in methylotrophen Hefen
DE69637154D1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
DE69616276T2 (de) Verfahren zur produktion von proteinen
ATE292689T1 (de) Verbesserte verfahren zur transfektion der t- zellen
ATE220714T1 (de) Verfahren zur herstellung von proteinen
ATE58170T1 (de) Fermentationsverfahren und erhaltene produkte.
ATE196165T1 (de) Methoden zur herstellung von protein c
ATE85644T1 (de) Verfahren zur erhoehung von gen-expression.
DE3877446D1 (de) Verfahren zur synthese von glutathion in hefen.
ATE266733T1 (de) Verfahren zur herstellung von heterologen polypeptiden in transformierten hefezellen
SE9301583D0 (sv) Yeast strain and methods for expressing heterologous proteins in yeast
ATE192780T1 (de) Verfahren zur rekombinanten herstellung von proteinen in hefe
ATE140484T1 (de) Verfahren zur expression von rezeptoren des menschlichen nervensystems in der hefe schizosaccharomyces pombe
DE69930118D1 (de) Verfahren zur herstellung von proteinen in transformierten hefezellen
KR960001120A (ko) 인간 플레이오트로핀 유전자의 발현벡터 및 효모에서의 인간 플레이오트로핀 단백질의 제조방법

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH AVENTIS PHARMA DEUTSCHLAND

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

Owner name: NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H

8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN